Blogs about MLNM - Stockpickr! Your Source for Stock Ideas

Blogs about MLNM

Blogs	Description	Date Updated
Russell 1,000 Stocks Up and Down the Most Since the 3/10 Bottom	Below we highlight four stock filters based on performance and overbought/oversold levels. The first two tables show the Russell 1,000 stocks that are up and down the most since the market bottomed on March 10th. As shown, MLNM is up the most at 93.84%, followed by VRTX, WMG, SGMS and CLR. Other notables on the list of winners include NTRI,... ...	May 05, 2008
Monday's Upgrades and Downgrades	UpgradesAmericanWest Banc (AWBC)- DA Davidson Neutral » Buy $18Northwest Airlines (NWA)- Credit Suisse Neutral » Outperform Delta Air Lines (DAL)- Credit Suisse Neutral » Outperform Seagate Tech (STX)- Caris & Company Average » Above Average EuroBancshares (EUBK)- Keefe Bruyette Mkt Perform » Outperform SBA Comm (SBAC)- Soleil Hold » Buy Crown Castle (CCI)- Soleil Hold » BuyMedco Health Solutions (MHS)- Credit Suisse Neutral » Outperform Diamond Offshor...	April 14, 2008
Analyst downgrades: HSY, DNA and GRMN	Filed under: Analyst reports, Analyst upgrades and downgrades, Hershey Co (HSY), Genentech Inc (DNA), Garmin Ltd (GRMN)MOST NOTEWORTHY: Hershey Foods, Genentech and Garmin were today's noteworthy downgrades: Bernstein downgraded Hershey Foods (NYSE: HSY) to Market Perform from Outperform, citing commodity cost pressures & slowing volume growth. Thomas Weisel downgraded Genentech (NYSE: DNA) to Market Weight from Overweight after the company reported Q1 results, due to Avastin gr...	April 11, 2008
Fast Money Recap	Word On The StreetWORD VIDEOGE Earnings TradeGeneral Electric (GE) is set to report earnings on Friday morning. What is the trade? Adami thinks GE will be a "tell" for Honeywell (HON). If GE reports a good number he said get long HON. Seymour said watch Siemens (SI) if GE's infrastructure division says anything bullish.Financial TakeA Fed auction Thursday could be signaling a end to the credit crisis. Is it time to buy financial stocks? What is the trade? Macke would only dip a toe into the fina...	April 10, 2008
As Institutions Sell Millennium On Buyout News, Which Biotech Stocks Will See Inflows? (ALXN, CEPH, CBST, IMCL, ONXX, SEPR, UTHR)	The $8.8 Billion cash buyout of Millennium Pharmaceuticals, Inc. (NASDAQ: MLNM) has created a situation worth monitoring today. It isn't just that this buyout... [[ This is a content summary only. Visit my website for full links, other content, and more! ]] ...	April 10, 2008
Cephalon (CEPH) gets a boost from Millennium (MLNM) buyout	Filed under: Deals, Good news, Options, Technical AnalysisCephalon Inc. (NASDAQ: CEPH) shares are trading higher today on news that Takeda Pharmaceutical, a Japanese firm, has agreed to buy Cephalon competitor Millennium Pharmaceuticals (NASDAQ: MLNM) for $25 a share. MLNM is trading up almost 50% to $24.45 currently, indicating that investors think this deal will most likely happen. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at...	April 10, 2008
Wall Street Rumors - April 10, 2008	Daily Rumors Covering the Global Markets. Subscribe to the Daily Rumors Update Here. Toyota Expands Partnership With Subaru Maker Fuji Heavy TOKYO — Toyota Motor Corp. (NYSE: TM) will boost its stake in Fuji Heavy Industries Ltd. to 16.5% from 8.7% as part of its expanded alliance with the maker of Subaru cars. News Corp., AOL Pursue Yahoo Deals Yahoo Inc. (NASDAQ: YHOO) and Time WarnerInc.’s (NYSE: TWX) AOL are closing in on a deal to combine their Internet operations, a move aimed...	April 10, 2008
Millennium Pharmaceuticals, Becoming Part of Takeda in Japan (MLNM)	Millennium Pharmaceuticals Inc. (NASDAQ: MLNM) is being acquired. Takeda Pharmaceuticals in Japan is paying some $8.8 Billion to acquire the biotech, which had... [[ This is a content summary only. Visit my website for full links, other content, and more! ]] ...	April 10, 2008
Millennium's healthy valuation	Filed under: Deals, Johnson and Johnson (JNJ)Yesterday, I met up with a health care venture capitalist. He mentioned that M&A is likely to be a big factor over the next few years. After all, major pharma companies will have a variety of their blockbuster drugs go off-patent. Well, interestingly enough, we got a mega-deal today; that is, Takeda Pharmaceuticals (the top drug company in Japan) has agreed to pay $8.8 billion for Millennium Pharmaceuticals (NASDAQ: MLNM), which develops biopharm...	April 10, 2008
Analyst initiations: WL, DRH and OMRI	Filed under: Analyst reports, Analyst initiationsMOST NOTEWORTHY: Wilmington Trust, DiamondRock Hospitality and Omrix Biopharm were today's noteworthy initiations: B. Riley initiated Wilmington Trust (NYSE: WL) with a Neutral rating and $33 target and points out the company has greater exposure to construction and development loans than most small- and mid-cap banks. DiamondRock Hospitality (NYSE: DRH) was assumed with a Market perform rating and $13.50 target at Kee...	March 31, 2008

Enter search text here: